SPARC Pledges Up To $10 Million For Drug Development Research at University of Michigan
January 13, 2020

Sun Pharma Advanced Research Company (SPARC) and the University of Michigan are collaborating to kickstart research and development  of potential new medications.

Long-Acting Reversible Contraception by Effervescent Microneedle Patch
November 18, 2019
Prof. Steven Schwendeman and collaborators publish paper on a new long-acting, self-administered device that delivers hormones beneath the skin’s surface.
Lasting Tumor Regression of Leukemia and Lymphoma in Mouse Models Achieved by U-M Compound
November 14, 2019
Dr. Shaomeng Wang, professor of medicinal chemistry at the U-M College of Pharmacy
A potent and selective degrader of the transcription factor STAT3 offers a new approach to a previously “undruggable” target.
Research Feature - Amy N. Thompson
October 7, 2019
Assessment of Self-monitoring of Blood Glucose in Individuals With Type 2 Diabetes Not Using Insulin
Research Feature - Amy Pasternak
October 7, 2019
Dr. Amy Pasternak

“Pediatric brain cancers traditionally have limited treatment options with poor treatment responses,” notes Amy Pasternak

Research Feature - Daniel Hertz
October 7, 2019

“Paclitaxel is a chemotherapeutic agent used in many cancer types including early stage breast cancer.

Research Feature - Timothy Cernak
October 7, 2019

Computers have shrunk in size and grown in power, all due to the magic of miniaturization. You likely have a smartphone in your pocket, which was made possible through miniaturization of transistor

Research Feature - Anna Schwendeman
October 7, 2019

Glioblastoma multiforme (GBM) is an aggressive primary brain tumor, for which there is currently no cure. The joint project between the laboratories of Dr.

Long-Acting Contraceptive Designed to be Self-Administered Via Microneedle Patch
February 21, 2019
“We select polymer materials to meet specific design objectives such as microneedle strength, biocompatibility, biodegradation and drug release time, and formulation stability,” said Steven Schwendeman, the Ara Paul Professor and chair of the Department of Pharmaceutical Sciences at the University of Michigan and a collaborator on this project.
A new long-acting contraceptive designed to be self-administered by women may provide a new family planning option, particularly in developing nations where access to health care can be limited, a recent study suggests. The contraceptive would be delivered using microneedle skin patch technology originally developed for the painless administration of vaccines.